Previous 10 | Next 10 |
Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to start the year. This continues their impressive streak from 2019. But are the current tech valuations sustainable? In a recent mark...
By Vinay Thapar and Frank Caruso US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. But investors can find good opportunities in the sector in companies with strong long-term business drivers that are relatively immune to ...
Despite the biotech industry having pockets of extreme and irrational ebullience, the largest part of the industry is systematically underfunded. It's also the highest-value-add part of the industry from a risk-adjusted basis. In this video, we have a philosophical discussion with the CEO of o...
It's time to talk about a new venture called EQRx. This has made quite a splash in the last few days at the JPMorgan investor conference, and it's been launched by Alexis Borisy (involved with founding and/or helping run CombinatoRx, Foundation, Blueprint, WarpDrive Bio, Editas, Relay, and oth...
VanEck Vectors Biotech ETF (NASDAQ: BBH ) - $0.4724 . 30-Day SEC Yield of 0.31% as of Dec 20. Payable Dec 30; for shareholders of record Dec 24; ex-div Dec 23. More news on: VanEck Vectors Biotech ETF, Dividend News, News on ETFs, ,
VanEck announced today the following 2019 annual distributions per share for its VanEck Vectors ® equity exchange-traded funds. The majority, and possibly all, of the dividend distributions will be paid out of net investment income earned by the Funds. A portion of these distributio...
VanEck Vectors Biotech ETF (NASDAQ: BBH ) - $0.4160 . 30-Day SEC Yield of 0.31% as of Nov. 26. Payable Dec 30; for shareholders of record Dec 24; ex-div Dec 23. Press Release More news on: VanEck Vectors Biotech ETF, Dividend News, News on ETFs, ,
VanEck announced today preliminary yearend distribution estimates for its VanEck Vectors ® exchange-traded funds. Please note that capital gains estimates were made as of October 31, 2019 and income estimates were made as of November 20, 2019, and are based upon the best information...
Aprea Therapeutics (NASDAQ: APRE ) opens for trading after raising the size of its IPO to 5.67M shares from 5M and pricing its IPO at $15 , the mid‐point of the $14‐$16 expected range. More news on: Aprea Therapeutics, Monopar Therapeutics, ADC Therapeutics SA, Healthcare st...
(Source - Pexels/Pixbay ) It is widely believed that the Healthcare sector is a safe sector in a recessionary environment because "people always need medical treatment." While that is historically true, it seems that many investors are underweighting the substantial risks in the sector. H...
News, Short Squeeze, Breakout and More Instantly...
VanEck Vectors Biotech ETF Company Name:
BBH Stock Symbol:
NASDAQ Market:
2024-05-08 00:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-28 06:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-29 14:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...